Novo Nordisk Lilly Shares Slump on Price-Cut Loom Plans
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Index funds and ETFs each have roles; this note explains when index funds offer a simpler, cost-effective path for many investors.
26,557 articlesNews of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Amazon unveils a sweeping $200 billion capex plan focused on AWS and AI infra, prompting investor debate on the compa...
Joby Aviation is set to report Q4 2025 results after the close, and the focal point for investors is cash burn. The c...
Ethereum rebounds from a mid-$1,700s slip, but the rebound sits at a critical crossroad. The question: is this a reli...
Rocket Companies closed 2025 with $6.7 billion in revenue and rising mortgage activity, alongside strategic deals tha...
Millennials hitting Peak 35 are wealthier than prior generations, signaling the great wealth transfer already underwa...
Geopolitical tremors surge as Iran will pick supreme leader within days. Traders weigh energy, currency, and consumer...
Analysts upgrade CrowdStrike ahead of earnings, citing modest guidance risk and a software sector pullback that has w...
Bitcoin bounced off a rough patch, but a veteran trader cautions that a final flush could wipe out late buyers. Analy...
Regulatory uncertainty over RESPA is transforming agent referrals into a legal battleground, pushing lenders and brok...
February layoffs slowed to 48,307, down sharply from January and far below last year's level. Analysts warn volatilit...
Oil edges toward a $100 threshold as geopolitical tensions intensify. Four key energy names—Exxon, Chevron, ConocoPhi...